#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B with anti factor IX Waldenstrom's macroglobulinaemia Osteosarcoma recurrent Hereditary hypophosphataemic rickets Autoimmune myositis Oropharyngeal squamous cell carcinoma Nephropathy Alexander disease Piriformis syndrome B-cell lymphoma recurrent Immune thrombocytopenia Acute leukaemia Systemic sclerosis pulmonary Mantle cell lymphoma recurrent Haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Chondrosarcoma – Trials in Disease Systemic mastocytosis – Life with Disease Pituitary-dependent Cushing’s syndrome – Diagnostics Vascular malformation Splenic marginal zone lymphoma – Treatment Skin angiosarcoma – Life with Disease Biotinidase deficiency – Life with Disease Shprintzen-Goldberg syndrome – Trials in Disease Marfan’s syndrome – Basic Information Choroid melanoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imipramine Hydrochloride Indapamide Vh4524184 Cctx-001 Pyridoxine Hydrochloride Pitolisant Parsaclisib Hydrochloride Tx200-Tr101 Levocabastine Hydrochloride Trametinib Dimethyl Sulfoxide MZE829 Carbamazepine (Ph. Eur.) Metoclopramide Hydrochloride Alectinib Hydrochloride Nilutamide Pirtobrutinib Censavudine Histidine Mrna-4157 Hst-1011 More therapies…

    Learn about Your Condition

    Stevens-Johnson syndrome Extra-osseous Ewing's sarcoma Intestinal infarction Endocrine disorder Lupus nephritis Dilated cardiomyopathy Peripheral artery angioplasty Hypotransferrinaemia Invasive breast carcinoma CADASIL Tricuspid valve disease Glioma Type 2 diabetes mellitus Urticaria cholinergic Portal hypertension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Orszagos Onkologiai Intezet

Orszagos Onkologiai Intezet

Rath Gyorgy Utca 7-9, Kerulet, Budapest, 1122, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Belinostat
    • Pralatrexate
    • Cyclophosphamide
    France Germany Hungary Italy Poland Spain

  • Long-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    • Non-small cell lung cancer
    Investigated Drugs:
    • Dabrafenib Mesylate
    • Trametinib
    Austria Czechia Denmark France Germany Hungary +2

  • Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Tazemetostat
    • Lenalidomide
    • Rituximab
    Belgium France Germany Hungary Italy Poland +1

  • Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Prostate cancer
    • Breast cancer
    Investigated Drugs:
    • Olaparib
    Belgium Bulgaria Czechia France Germany Hungary +6

  • Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Topotecan
    Austria Belgium Czechia France Germany Greece +7

  • Study on the Safety and Effectiveness of HDP-101 for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    2 1 1
    Investigated Drugs:
    • Hdp-101
    Germany Hungary Poland Romania Spain

  • Study on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm
    • Neoplasm malignant
    Investigated Drugs:
    • Vemurafenib
    • Binimetinib
    • Encorafenib
    Czechia France Germany Greece Hungary Italy +4

  • Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Saruparib
    • Abemaciclib
    • Camizestrant
    Austria Bulgaria Czechia France Germany Hungary +4

  • Study on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma

    Recruiting

    4 1 1
    Investigated Drugs:
    • Pembrolizumab
    • Resiquimod Sulfate
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Dexamethasone
    • Dexamethasone Acetate
    Austria Czechia Denmark Finland France Germany +8
Previous Page
1 … 3 4 5 6 7 … 17
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!